ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Johnson Matthey to shutter Pennsylvania facility

by Rick Mullin
April 22, 2018 | APPEARED IN VOLUME 96, ISSUE 17

Johnson Matthey says it will close its drug chemical plant in Conshohocken, Pa., by the end of the year, claiming the facility does not comport with a focus on “complex, high-value, low-volume specialty products” in its health care business. The British firm more than doubled its controlled-substance manufacturing capacity when it acquired the plant from Lonza in 2011. The closure will eliminate 80 jobs, according to Matthey.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment